Company Profile
Autifony Therapeutics Limited
07543962•Private Limited With Share Capital
Get Full Access
25/02/2011
15 years
6
28
72110
moderate risk
Company Overview
Registration, classification & business activity
Autifony Therapeutics Limited (07543962) is a private limited with share capital incorporated on 25/02/2011 (15 years old) and registered in stevenage, SG12FX. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Autifony therapeutics limited (“autifony”) is a clinical stage biotechnology company dedicated to developing new medicines to treat rare genetic cns disorders by deploying its pioneering ion channel drug discovery platform.
Financial Overview
£16.73M
£1.09M
£15.63M
£4.11M
£13.43M
Key Metrics
28
Employees
6
Directors
101
Shareholders
19
Patents
Board of Directors
Charges
1
Registered
0
Outstanding
0
Part Satisfied
1
Satisfied
Innovate Grants
This company received a grant of £894585.0 for Development Of A Novel Potassium Ion Channel Modulator For The Treatment Of Dementia. The project started on 01/02/2017 and ended on 30/09/2018.
Import / Export
Risk Assessment
moderate risk
International Score
Future Factor
good
Performance Rating